{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aggregates", "Alpha-synuclein", "Alzheimer\u2019s disease", "Amylin", "Amyloid beta", "Amyloid inhibitors", "Flavonoids", "Misfolded proteins", "Natural compounds", "Parkinson\u2019s disease", "Polyphenols", "Prion diseases", "Protein misfolding disorders", "Tau", "Type 2 diabetes"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30030591", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "10"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1007/s00018-018-2872-2"], "Journal": {"ISSN": "1420-9071", "JournalIssue": {"Volume": "75", "Issue": "19", "PubDate": {"Year": "2018", "Month": "Oct"}}, "Title": "Cellular and molecular life sciences : CMLS", "ISOAbbreviation": "Cell Mol Life Sci"}, "ArticleTitle": "Inhibition of protein misfolding and aggregation by natural phenolic compounds.", "Pagination": {"StartPage": "3521", "EndPage": "3538", "MedlinePgn": "3521-3538"}, "Abstract": {"AbstractText": ["Protein misfolding and aggregation into fibrillar deposits is a common feature of a large group of degenerative diseases affecting the central nervous system or peripheral organs, termed protein misfolding disorders (PMDs). Despite their established toxic nature, clinical trials aiming to reduce misfolded aggregates have been unsuccessful in treating or curing PMDs. An interesting possibility for disease intervention is the regular intake of natural food or herbal extracts, which contain active molecules that inhibit aggregation or induce the disassembly of misfolded aggregates. Among natural compounds, phenolic molecules are of particular interest, since most have dual activity as amyloid aggregation inhibitors and antioxidants. In this article, we review many phenolic natural compounds which have been reported in diverse model systems to have the potential to delay or prevent the development of various PMDs, including Alzheimer's and Parkinson's diseases, prion diseases, amyotrophic lateral sclerosis, systemic amyloidosis, and type 2 diabetes. The lower toxicity of natural compounds compared to synthetic chemical molecules suggest that they could serve as a good starting point to discover protein misfolding inhibitors that might be useful for the treatment of various incurable diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e9 de Tunis El Manar, Facult\u00e9 des Sciences de Tunis, 2092, Tunis, Tunisia."}, {"Identifier": [], "Affiliation": "Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj-C\u00e9dria, BP 901, 2050, Hammam-Lif, Tunisia."}], "LastName": "Dhouafli", "ForeName": "Zohra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA."}], "LastName": "Cuanalo-Contreras", "ForeName": "Karina", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj-C\u00e9dria, BP 901, 2050, Hammam-Lif, Tunisia."}], "LastName": "Hayouni", "ForeName": "El Akrem", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA."}], "LastName": "Mays", "ForeName": "Charles E", "Initials": "CE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA."}], "LastName": "Soto", "ForeName": "Claudio", "Initials": "C"}, {"Identifier": ["0000-0003-3875-0889"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. Ines.M.Gonzalez@uth.tmc.edu."}, {"Identifier": [], "Affiliation": "Department of Cell Biology, Networking Research Center on Neurodegenerative Diseases (CIBERNED), Facultad Ciencias, Universidad de Malaga, M\u00e1laga, Spain. Ines.M.Gonzalez@uth.tmc.edu."}], "LastName": "Moreno-Gonzalez", "ForeName": "Ines", "Initials": "I"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cell Mol Life Sci", "NlmUniqueID": "9705402", "ISSNLinking": "1420-682X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Amyloidosis"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phenols"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Prion Diseases"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Protein Aggregation, Pathological"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Folding"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Proteostasis Deficiencies"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Moreno-Gonzalez I, Soto C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin Cell Dev Biol. 2011;22:482\u2013487. doi: 10.1016/j.semcdb.2011.04.002.", "ArticleIdList": ["10.1016/j.semcdb.2011.04.002", "PMC3175247", "21571086"]}, {"Citation": "Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49\u201360. doi: 10.1038/nrn1007.", "ArticleIdList": ["10.1038/nrn1007", "12511861"]}, {"Citation": "Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5\u201336. doi: 10.1007/s00401-009-0532-1.", "ArticleIdList": ["10.1007/s00401-009-0532-1", "19381658"]}, {"Citation": "Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet. 2004;363:1783\u20131793. doi: 10.1016/S0140-6736(04)16305-8.", "ArticleIdList": ["10.1016/S0140-6736(04)16305-8", "15172778"]}, {"Citation": "Hetz C, Soto C. Protein misfolding and disease: the case of prion disorders. Cell Mol Life Sci. 2003;60:133\u2013143. doi: 10.1007/s000180300009.", "ArticleIdList": ["10.1007/s000180300009", "12613663"]}, {"Citation": "Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197\u2013206. doi: 10.1038/nature20413.", "ArticleIdList": ["10.1038/nature20413", "PMC5585017", "27830784"]}, {"Citation": "Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83\u201398. doi: 10.1016/S1474-4422(10)70245-3.", "ArticleIdList": ["10.1016/S1474-4422(10)70245-3", "21163446"]}, {"Citation": "Westermark GT, F\u00e4ndrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol Mech Dis. 2015;10:321\u2013344. doi: 10.1146/annurev-pathol-020712-163913.", "ArticleIdList": ["10.1146/annurev-pathol-020712-163913", "25387054"]}, {"Citation": "Mukherjee A, Morales-Scheihing D, Butler PC, Soto C. Type 2 diabetes as a protein misfolding disease. Trends Mol Med. 2015;21:439\u2013449. doi: 10.1016/j.molmed.2015.04.005.", "ArticleIdList": ["10.1016/j.molmed.2015.04.005", "PMC4492843", "25998900"]}, {"Citation": "Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86:1036\u20131043. doi: 10.1136/jnnp-2014-308724.", "ArticleIdList": ["10.1136/jnnp-2014-308724", "25604431"]}, {"Citation": "Morales R, Moreno-Gonzalez I, Soto C. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog. 2013 doi: 10.1371/journal.ppat.1003537.", "ArticleIdList": ["10.1371/journal.ppat.1003537", "PMC3777858", "24068917"]}, {"Citation": "Nelson R, Sawaya MR, Balbirnie M, Madsen A\u00d8, Riekel C, Grothe R, Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435:773\u2013778. doi: 10.1038/nature03680.", "ArticleIdList": ["10.1038/nature03680", "PMC1479801", "15944695"]}, {"Citation": "Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta Mol Basis Dis. 2004;1739:5\u201325. doi: 10.1016/j.bbadis.2004.08.004.", "ArticleIdList": ["10.1016/j.bbadis.2004.08.004", "15607113"]}, {"Citation": "Monsellier E, Chiti F. Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep. 2007;8:737\u2013742. doi: 10.1038/sj.embor.7401034.", "ArticleIdList": ["10.1038/sj.embor.7401034", "PMC1978086", "17668004"]}, {"Citation": "Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999;24:329\u2013332. doi: 10.1016/S0968-0004(99)01445-0.", "ArticleIdList": ["10.1016/S0968-0004(99)01445-0", "10470028"]}, {"Citation": "Duran-Aniotz C, Moreno-Gonzalez I, Morales R. Amyloid aggregates: role in protein misfolding disorders. Rev Med Chile. 2013;141:495\u2013505. doi: 10.4067/S0034-98872013000400011.", "ArticleIdList": ["10.4067/S0034-98872013000400011", "23900371"]}, {"Citation": "Andre R, Tabrizi SJ. Misfolded PrP and a novel mechanism of proteasome inhibition. Prion. 2012;6:32\u201336. doi: 10.4161/pri.6.1.18272.", "ArticleIdList": ["10.4161/pri.6.1.18272", "PMC3338962", "22453175"]}, {"Citation": "Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181:1426\u20131435. doi: 10.1016/j.ajpath.2012.06.033.", "ArticleIdList": ["10.1016/j.ajpath.2012.06.033", "PMC3463637", "22867711"]}, {"Citation": "Cuanalo-Contreras K, Mukherjee A, Soto C. Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int J Cell Biol. 2013;2013:638083. doi: 10.1155/2013/638083.", "ArticleIdList": ["10.1155/2013/638083", "PMC3855986", "24348562"]}, {"Citation": "Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141:1146\u20131158. doi: 10.1016/j.cell.2010.05.008.", "ArticleIdList": ["10.1016/j.cell.2010.05.008", "PMC3647462", "20541250"]}, {"Citation": "Nixon RA, Yang DS, Lee JH. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy. 2008;4:590\u2013599. doi: 10.4161/auto.6259.", "ArticleIdList": ["10.4161/auto.6259", "18497567"]}, {"Citation": "Sanchez-Varo R, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Baglietto-Vargas D, Moreno-Gonzalez I, De Castro V, Jimenez S, Ruano D, Vizuete M, Davila JC, Garcia-Verdugo JM, Jimenez AJ, Vitorica J, Gutierrez A. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer\u2019s mice hippocampus. Acta Neuropathol. 2012;123:53\u201370. doi: 10.1007/s00401-011-0896-x.", "ArticleIdList": ["10.1007/s00401-011-0896-x", "PMC3249205", "22020633"]}, {"Citation": "Kelly JW. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol. 1996;6:11\u201317. doi: 10.1016/S0959-440X(96)80089-3.", "ArticleIdList": ["10.1016/S0959-440X(96)80089-3", "8696966"]}, {"Citation": "Soto C, Estrada L, Castilla J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci. 2006;31:150\u2013155. doi: 10.1016/j.tibs.2006.01.002.", "ArticleIdList": ["10.1016/j.tibs.2006.01.002", "16473510"]}, {"Citation": "Jarrett JT, Lansbury PT., Jr Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer\u2019s disease and scrapie? Cell. 1993;73:1055\u20131058. doi: 10.1016/0092-8674(93)90635-4.", "ArticleIdList": ["10.1016/0092-8674(93)90635-4", "8513491"]}, {"Citation": "Moreno-Gonzalez I, Edwards G, III, Salvadores N, Shahnawaz M, Diaz-Espinoza R, Soto C. Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding. Mol Psychiatry. 2017;22:1327\u20131334. doi: 10.1038/mp.2016.230.", "ArticleIdList": ["10.1038/mp.2016.230", "PMC5495631", "28044060"]}, {"Citation": "Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C. Molecular cross talk between misfolded proteins in animal models of Alzheimer\u2019s and prion diseases. J Neurosci. 2010;30:4528\u20134535. doi: 10.1523/JNEUROSCI.5924-09.2010.", "ArticleIdList": ["10.1523/JNEUROSCI.5924-09.2010", "PMC2859074", "20357103"]}, {"Citation": "Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 2001;498:204\u2013207. doi: 10.1016/S0014-5793(01)02486-3.", "ArticleIdList": ["10.1016/S0014-5793(01)02486-3", "11412858"]}, {"Citation": "Estrada LD, Soto C. Inhibition of protein misfolding and aggregation by small rationally-designed peptides. Curr Pharm Des. 2006;12:2557\u20132567. doi: 10.2174/138161206777698792.", "ArticleIdList": ["10.2174/138161206777698792", "16842178"]}, {"Citation": "Soto C, Sigurdsson EM, Morelli L, Kumar RA, Casta\u00f1o EM, Frangione B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer\u2019s therapy. Nat Med. 1998;4:822\u2013826. doi: 10.1038/nm0798-822.", "ArticleIdList": ["10.1038/nm0798-822", "9662374"]}, {"Citation": "Ladiwala ARA, Dordick JS, Tessier PM. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J Biol Chem. 2011;286:3209\u20133218. doi: 10.1074/jbc.M110.173856.", "ArticleIdList": ["10.1074/jbc.M110.173856", "PMC3030325", "21098486"]}, {"Citation": "Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, Tabrizi SJ. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun. 2011;2:281. doi: 10.1038/ncomms1282.", "ArticleIdList": ["10.1038/ncomms1282", "PMC3104518", "21505437"]}, {"Citation": "Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog. 2009;5:e1000426. doi: 10.1371/journal.ppat.1000426.", "ArticleIdList": ["10.1371/journal.ppat.1000426", "PMC2673690", "19424437"]}, {"Citation": "Sarnataro D, Pepe A, Altamura G, De Simone I, Pesapane A, Nitsch L, Montuori N, Lavecchia A, Zurzolo C. The 37/67 kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein. Sci Rep. 2016;6:24457. doi: 10.1038/srep24457.", "ArticleIdList": ["10.1038/srep24457", "PMC4829897", "27071549"]}, {"Citation": "Valera E, Masliah E. Immunotherapy for neurodegenerative diseases: focus on \u03b1-synucleinopathies. Pharmacol Ther. 2013;138:311\u2013322. doi: 10.1016/j.pharmthera.2013.01.013.", "ArticleIdList": ["10.1016/j.pharmthera.2013.01.013", "PMC3925783", "23384597"]}, {"Citation": "Wisniewski T, Go\u00f1i F. Immunotherapeutic approaches for Alzheimer\u2019s disease. Neuron. 2015;85:1162\u20131176. doi: 10.1016/j.neuron.2014.12.064.", "ArticleIdList": ["10.1016/j.neuron.2014.12.064", "PMC4366618", "25789753"]}, {"Citation": "Pedersen JT, Sigurdsson EM. Tau immunotherapy for Alzheimer\u2019s disease. Trends Mol Med. 2015;21:394\u2013402. doi: 10.1016/j.molmed.2015.03.003.", "ArticleIdList": ["10.1016/j.molmed.2015.03.003", "25846560"]}, {"Citation": "Rosenblum WI. Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult. Neurobiol Aging. 2014;35:969\u2013974. doi: 10.1016/j.neurobiolaging.2013.10.085.", "ArticleIdList": ["10.1016/j.neurobiolaging.2013.10.085", "24210593"]}, {"Citation": "Van Dyck CH. Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise. Biol Psychiatry. 2018;83:311\u2013319. doi: 10.1016/j.biopsych.2017.08.010.", "ArticleIdList": ["10.1016/j.biopsych.2017.08.010", "PMC5767539", "28967385"]}, {"Citation": "Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2:1231\u20131246. doi: 10.3390/nu2121231.", "ArticleIdList": ["10.3390/nu2121231", "PMC3257627", "22254006"]}, {"Citation": "Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317\u2013333. doi: 10.1111/j.1753-4887.1998.tb01670.x.", "ArticleIdList": ["10.1111/j.1753-4887.1998.tb01670.x", "9838798"]}, {"Citation": "D\u2019Archivio M, Filesi C, Var\u00ec R, Scazzocchio B, Masella R. Bioavailability of the polyphenols: status and controversies. Int J Mol Sci. 2010;11:1321\u20131342. doi: 10.3390/ijms11041321.", "ArticleIdList": ["10.3390/ijms11041321", "PMC2871118", "20480022"]}, {"Citation": "Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Asp Med. 2010;31:446\u2013467. doi: 10.1016/j.mam.2010.09.007.", "ArticleIdList": ["10.1016/j.mam.2010.09.007", "20854839"]}, {"Citation": "Maruszak A, Pilarski A, Murphy T, Branch N, Thuret S. Hippocampal neurogenesis in Alzheimer\u2019s disease: is there a role for dietary modulation? J Alzheimer\u2019s Dis. 2014;38:11\u201338. doi: 10.3233/JAD-131004.", "ArticleIdList": ["10.3233/JAD-131004", "23948932"]}, {"Citation": "Dias GP, Cavegn N, Nix A, Do Nascimento Bevilaqua MC, Stangl D, Zainuddin MSA, Nardi AE, Gardino PF, Thuret S. The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev. 2012;2012:541971. doi: 10.1155/2012/541971.", "ArticleIdList": ["10.1155/2012/541971", "PMC3395274", "22829957"]}, {"Citation": "Zhao L, Hou L, Sun H, Yan X, Sun X, Li J, Bian Y, Chu Y, Liu Q. Apigenin isolated from the medicinal plant Elsholtzia rugulosa prevents \u03b2-Amyloid 25\u201335-induces toxicity in rat cerebral microvascular endothelial cells. Molecules. 2011;16:4005\u20134019. doi: 10.3390/molecules16054005.", "ArticleIdList": ["10.3390/molecules16054005"]}, {"Citation": "Florio P, Folli C, Cianci M, Del Rio D, Zanotti G, Berni R. Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites. J Biol Chem. 2015;290:29769\u201329780. doi: 10.1074/jbc.M115.690172.", "ArticleIdList": ["10.1074/jbc.M115.690172", "PMC4705982", "26468275"]}, {"Citation": "Amini R, Yazdanparast R, Bahramikia S. Apigenin reduces human insulin fibrillation in vitro andprotects SK-N-Mc cellsagainstinsulinamyloids. Int J Biol Macromol. 2013;60:334\u2013340. doi: 10.1016/j.ijbiomac.2013.06.013.", "ArticleIdList": ["10.1016/j.ijbiomac.2013.06.013", "23777711"]}, {"Citation": "Thapa A, Woo ER, Chi EY, Sharoar MG, Jin HG, Shin SY, Park IS. Biflavonoids are superior to monoflavonoids in inhibiting amyloid beta toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry. 2011;50:2445\u20132455. doi: 10.1021/bi101731d.", "ArticleIdList": ["10.1021/bi101731d", "21322641"]}, {"Citation": "Caruana M, H\u00f6gen T, Levin J, Hillmer A, Giese A, Vassallo N. Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 2011;585:1113\u20131120. doi: 10.1016/j.febslet.2011.03.046.", "ArticleIdList": ["10.1016/j.febslet.2011.03.046", "21443877"]}, {"Citation": "Necula M, Kayed R, Milton S, Glabe CG. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem. 2007;282:10311\u201310324. doi: 10.1074/jbc.M608207200.", "ArticleIdList": ["10.1074/jbc.M608207200", "17284452"]}, {"Citation": "Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer\u2019s disease mouse model. Molecules. 2013;18:9949\u20139965. doi: 10.3390/molecules18089949.", "ArticleIdList": ["10.3390/molecules18089949", "PMC6270497", "23966081"]}, {"Citation": "De la Luz C\u00e1diz-Gurrea M, Fern\u00e1ndez-Arroyo S, Segura-Carretero A. Pine bark and green tea concentrated extracts: antioxidant activity and comprehensive characterization of bioactive compounds by HPLC\u2013ESI-QTOF-MS. Int J Mol Sci. 2014;15:20382\u201320402. doi: 10.3390/ijms151120382.", "ArticleIdList": ["10.3390/ijms151120382", "PMC4264173", "25383680"]}, {"Citation": "Betts JW, Sharili AS, Phee LM, Wareham DW. In vitro activity of epigallocatechin gallate and quercetin alone and in combination versus clinical isolates of methicillin-resistant Staphylococcus aureus [J] J Nat Prod. 2015;78:2145\u20132148. doi: 10.1021/acs.jnatprod.5b00471.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00471", "26267658"]}, {"Citation": "BituPinto N, DaSilvaAlexandre B, Neves KRT, Silva AH, Leal LKAM, Viana GSB. Neuroprotective properties of the standardized extract from Camellia sinensis (green tea) and its main bioactive components, epicatechin and epigallocatechin gallate, in the 6-OHDA model of Parkinson\u2019s disease. Evid Based Complement Altern Med. 2015 doi: 10.1155/2015/161092.", "ArticleIdList": ["10.1155/2015/161092", "PMC4488543", "26167188"]}, {"Citation": "Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci. 2010;107:7710\u20137715. doi: 10.1073/pnas.0910723107.", "ArticleIdList": ["10.1073/pnas.0910723107", "PMC2867908", "20385841"]}, {"Citation": "Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol. 2008;15:558\u2013566. doi: 10.1038/nsmb.1437.", "ArticleIdList": ["10.1038/nsmb.1437", "18511942"]}, {"Citation": "Wobst HJ, Sharma A, Diamond MI, Wanker EE, Bieschke J. The green tea polyphenol (\u2212)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios. FEBS Lett. 2015;589:77\u201383. doi: 10.1016/j.febslet.2014.11.026.", "ArticleIdList": ["10.1016/j.febslet.2014.11.026", "PMC4565179", "25436420"]}, {"Citation": "Cao P, Raleigh DP. Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry. 2012;51:2670\u20132683. doi: 10.1021/bi2015162.", "ArticleIdList": ["10.1021/bi2015162", "PMC3329122", "22409724"]}, {"Citation": "Ferreira N, Saraiva MJ, Almeida MR. Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy. Amyloid. 2012;19(Suppl 1):39\u201342. doi: 10.3109/13506129.2012.668502.", "ArticleIdList": ["10.3109/13506129.2012.668502", "22620965"]}, {"Citation": "Ferreira N, Saraiva MJ, Almeida MR. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 2011;585:2424\u20132430. doi: 10.1016/j.febslet.2011.06.030.", "ArticleIdList": ["10.1016/j.febslet.2011.06.030", "21740906"]}, {"Citation": "Ehrnhoefer DE, Duennwald M, Markovic P, Wacker JL, Engemann S, Roark M, Legleiter J, Marsh JL, Thompson LM, Lindquist S, Muchowski PJ, Wanker EE. Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington\u2019s disease models. Hum Mol Genet. 2006;15:2743\u20132751. doi: 10.1093/hmg/ddl210.", "ArticleIdList": ["10.1093/hmg/ddl210", "16893904"]}, {"Citation": "Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci. 2011;12:5592\u20135603. doi: 10.3390/ijms12095592.", "ArticleIdList": ["10.3390/ijms12095592", "PMC3189735", "22016611"]}, {"Citation": "Franko A, Rodriguez Camargo DC, B\u00f6ddrich A, Garg D, Rodriguez Camargo A, Rathkolb B, Janik D, Aichler M, Feuchtinger A, Neff F, Fuchs H, Wanker EE, Reif B, H\u00e4ring HU, Peter A, Hrab\u011b De Angelis M. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice. Sci Rep. 2018;8:1116. doi: 10.1038/s41598-017-18807-8.", "ArticleIdList": ["10.1038/s41598-017-18807-8", "PMC5773570", "29348618"]}, {"Citation": "Mereles D, Buss SJ, Hardt SE, Hunstein W, Katus HA. Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. Clin Res Cardiol. 2010;99:483\u2013490. doi: 10.1007/s00392-010-0142-x.", "ArticleIdList": ["10.1007/s00392-010-0142-x", "20221615"]}, {"Citation": "Kim H, Park BS, Lee KG, Cheol YC, Sung SJ, Kim YH, Lee SE. Effects of naturally occurring compounds on fibril formation and oxidative stress of \u03b2-amyloid. J Agric Food Chem. 2005;53:8537\u20138541. doi: 10.1021/jf051985c.", "ArticleIdList": ["10.1021/jf051985c", "16248550"]}, {"Citation": "Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, Abe K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci Lett. 2008;444:280\u2013285. doi: 10.1016/j.neulet.2008.08.052.", "ArticleIdList": ["10.1016/j.neulet.2008.08.052", "18761054"]}, {"Citation": "Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol Neurobiol. 2017;54:2269\u20132285. doi: 10.1007/s12035-016-9795-4.", "ArticleIdList": ["10.1007/s12035-016-9795-4", "26944285"]}, {"Citation": "Maher P, Dargusch R, Bodai L, Gerard PE, Purcell JM, Lawrence Marsh J. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington\u2019s disease. Hum Mol Genet. 2011;20:261\u2013270. doi: 10.1093/hmg/ddq460.", "ArticleIdList": ["10.1093/hmg/ddq460", "PMC3005900", "20952447"]}, {"Citation": "Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O, Maher P. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer\u2019s disease transgenic mice. Aging Cell. 2014;13:379\u2013390. doi: 10.1111/acel.12185.", "ArticleIdList": ["10.1111/acel.12185", "PMC3954948", "24341874"]}, {"Citation": "Bhat WF, Bhat SA, Bano B. Evaluation of polyphenols as possible therapeutics for amyloidoses: comparative analysis of Kaempferol and Catechin. Int J Biol Macromol. 2015;81:60\u201368. doi: 10.1016/j.ijbiomac.2015.07.052.", "ArticleIdList": ["10.1016/j.ijbiomac.2015.07.052", "26231329"]}, {"Citation": "Roth A, Schaffner W, Hertel C. Phytoestrogen kaempferol (3,4\u2032,5,7-tetrahydroxyflavone) protects PC12 and T47D cells from \u03b2-amyloid\u2013induced toxicity. J Neurosci Res. 1999;57:399\u2013404. doi: 10.1002/(SICI)1097-4547(19990801)57:3<399::AID-JNR12>3.0.CO;2-W.", "ArticleIdList": ["10.1002/(SICI)1097-4547(19990801)57:3<399::AID-JNR12>3.0.CO;2-W", "10412031"]}, {"Citation": "Kim JK, Shin E-C, Kim CR, Park GG, Choi SJ, Park S-G, Shin D-H. Effects of brussels sprouts and their phytochemical components on oxidative stress-induced neuronal damages in PC12 cells and ICR mice. J Med Food. 2013;16:1057\u20131061. doi: 10.1089/jmf.2012.0280.", "ArticleIdList": ["10.1089/jmf.2012.0280", "24175656"]}, {"Citation": "Kim JK, Choi SJ, Cho HY, Hwang H-J, Kim YJ, Lim ST, Kim C-J, Kim HK, Peterson S, Shin D-H. Protective effects of kaempferol (3,4\u2019,5,7-tetrahydroxyflavone) against amyloid beta peptide (Abeta)-induced neurotoxicity in ICR mice. Biosci Biotechnol Biochem. 2010;74:397\u2013401. doi: 10.1271/bbb.90585.", "ArticleIdList": ["10.1271/bbb.90585", "20139605"]}, {"Citation": "Beg T, Jyoti S, Naz F, Rahul X, Ali F, Ali SK, Reyad AM, Siddique YH. Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets. 2018 doi: 10.2174/1871527317666180508123050.", "ArticleIdList": ["10.2174/1871527317666180508123050", "29745345"]}, {"Citation": "Yang S, Liu W, Lu S, Tian YZ, Wang WY, Ling TJ, Liu RT. A novel multifunctional compound Camellikaempferoside B decreases A\u03b2 production, interferes with A\u03b2 aggregation, and prohibits A\u03b2-mediated neurotoxicity and neuroinflammation. ACS Chem Neurosci. 2016;7:505\u2013518. doi: 10.1021/acschemneuro.6b00091.", "ArticleIdList": ["10.1021/acschemneuro.6b00091", "27015590"]}, {"Citation": "Ren R, Shi C, Cao J, Sun Y, Zhao X, Guo Y, Wang C, Lei H, Jiang H, Ablat N, Xu J, Li W, Ma Y, Qi X, Ye M, Pu X, Han H. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson\u2019s disease. Sci Rep. 2016;6:22135. doi: 10.1038/srep22135.", "ArticleIdList": ["10.1038/srep22135", "PMC4764910", "26906725"]}, {"Citation": "Lemkul JA, Bevan DR. Morin inhibits the early stages of amyloid \u03b2-peptide aggregation by altering tertiary and quaternary interactions to produce \u201coff-pathway\u201d structures. Biochemistry. 2012;51:5990\u20136009. doi: 10.1021/bi300113x.", "ArticleIdList": ["10.1021/bi300113x", "22762350"]}, {"Citation": "Noor H, Cao P, Raleigh DP. Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci. 2012;21:373\u2013382. doi: 10.1002/pro.2023.", "ArticleIdList": ["10.1002/pro.2023", "PMC3375438", "22238175"]}, {"Citation": "Patel P, Parmar K, Das M. Inhibition of insulin amyloid fibrillation by morin hydrate. Int J Biol Macromol. 2018;108:225\u2013239. doi: 10.1016/j.ijbiomac.2017.11.168.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.11.168", "29197568"]}, {"Citation": "Du Y, Qu J, Zhang W, Bai M, Zhou Q, Zhang Z, Li Z, Miao J. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms. Neuropharmacology. 2016;108:1\u201313. doi: 10.1016/j.neuropharm.2016.04.008.", "ArticleIdList": ["10.1016/j.neuropharm.2016.04.008", "27067919"]}, {"Citation": "Das S, Stark L, Musgrave IF, Pukala T, Smid SD. Bioactive polyphenol interactions with \u03b2 amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity. Food Funct. 2016;7:1138\u20131146. doi: 10.1039/C5FO01281C.", "ArticleIdList": ["10.1039/C5FO01281C", "26815043"]}, {"Citation": "Taniguchi S, Suzuki N, Masuda M, Hisanaga SI, Iwatsubo T, Goedert M, Hasegawa M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem. 2005;280:7614\u20137623. doi: 10.1074/jbc.M408714200.", "ArticleIdList": ["10.1074/jbc.M408714200", "15611092"]}, {"Citation": "Takahashi R, Ono K, Takamura Y, Mizuguchi M, Ikeda T, Nishijo H, Yamada M. Phenolic compounds prevent the oligomerization of \u03b1-synuclein and reduce synaptic toxicity. J Neurochem. 2015;134:943\u2013955. doi: 10.1111/jnc.13180.", "ArticleIdList": ["10.1111/jnc.13180", "26016728"]}, {"Citation": "Ono K, Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem. 2006;97:105\u2013115. doi: 10.1111/j.1471-4159.2006.03707.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.03707.x", "16524383"]}, {"Citation": "Zelus C, Fox A, Calciano A, Faridian BS, Nogaj LA, Moffet DA. Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity. Open Biochem J. 2012;6:66\u201370. doi: 10.2174/1874091X01206010066.", "ArticleIdList": ["10.2174/1874091X01206010066", "PMC3394101", "22792130"]}, {"Citation": "He J, Wang Y, Chang AK, Xu L, Wang N, Chong X, Li H, Zhang B, Jones GW, Song Y. Myricetin prevents fibrillogenesis of hen egg white lysozyme. J Agric Food Chem. 2014;62:9442\u20139449. doi: 10.1021/jf5025449.", "ArticleIdList": ["10.1021/jf5025449", "25196984"]}, {"Citation": "Matsuzaki K, Noguch T, Wakabayashi M, Ikeda K, Okada T, Ohashi Y, Hoshino M, Naiki H. Inhibitors of amyloid \u03b2-protein aggregation mediated by GM1-containing raft-like membranes. Biochim Biophys Acta. 2007;1768:122\u2013130. doi: 10.1016/j.bbamem.2006.09.014.", "ArticleIdList": ["10.1016/j.bbamem.2006.09.014", "17069749"]}, {"Citation": "Zhu M, Han S, Fink AL. Oxidized quercetin inhibits \u03b1-synuclein fibrillization. Biochim Biophys Acta. 2013;1830:2872\u20132881. doi: 10.1016/j.bbagen.2012.12.027.", "ArticleIdList": ["10.1016/j.bbagen.2012.12.027", "23295967"]}, {"Citation": "Jiang W, Luo T, Li S, Zhou Y, Shen XY, He F, Xu J, Wang HQ. Quercetin protects against okadaic acid-induced injury via MAPK and PI3K/Akt/GSK3\u03b2 signaling pathways in HT22 hippocampal neurons. PLoS One. 2016;11:e0152371. doi: 10.1371/journal.pone.0152371.", "ArticleIdList": ["10.1371/journal.pone.0152371", "PMC4822954", "27050422"]}, {"Citation": "Li Y, Zhou S, Li J, Sun Y, Hasimu H, Liu R, Zhang T. Quercetin protects human brain microvascular endothelial cells from fibrillar \u03b2-amyloid1-40-induced toxicity. Acta Pharm Sin B. 2015;5:47\u201354. doi: 10.1016/j.apsb.2014.12.003.", "ArticleIdList": ["10.1016/j.apsb.2014.12.003", "PMC4629123", "26579424"]}, {"Citation": "Sabogal-Gu\u00e1queta AM, Mu\u00f1oz-Manco JI, Ram\u00edrez-Pineda JR, Lamprea-Rodriguez M, Osorio E, Cardona-G\u00f3mez GP. The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology. 2015;93:134\u2013145. doi: 10.1016/j.neuropharm.2015.01.027.", "ArticleIdList": ["10.1016/j.neuropharm.2015.01.027", "PMC4387064", "25666032"]}, {"Citation": "Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer\u2019s disease. FASEB J. 2013;27:769\u2013781. doi: 10.1096/fj.12-212118.", "ArticleIdList": ["10.1096/fj.12-212118", "PMC3545533", "23097297"]}, {"Citation": "Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, Ito M, Miyamoto KI, Tsuji A, Kawai Y, Terao J. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med. 2011;51:1329\u20131336. doi: 10.1016/j.freeradbiomed.2011.06.017.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.06.017", "21741473"]}, {"Citation": "Du WJ, Guo JJ, Gao MT, Hu SQ, Dong XY, Han YF, Liu FF, Jiang S, Sun Y. Brazilin inhibits amyloid \u03b2-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity. Sci Rep. 2015;5:7992. doi: 10.1038/srep07992.", "ArticleIdList": ["10.1038/srep07992", "PMC4303869", "25613018"]}, {"Citation": "Deng Z, Wang X, Zhao H, Cui S, Yao Q, Bai H. A validated LC-MS/MS method for rapid determination of brazilin in rat plasma and its application to a pharmacokinetic study. Biomed Chromatogr. 2013;27:802\u2013806. doi: 10.1002/bmc.2863.", "ArticleIdList": ["10.1002/bmc.2863", "23303567"]}, {"Citation": "Yan-Yan J, Yan L, Ying S, Jinyi Z, Fang D, Yuan S, Ai-Dong WJ. A simple high-performance liquid chromatographic method for the determination of brazilin and its application to a pharmacokinetic study in rats. J Ethnopharmacol. 2014;151:108\u2013113. doi: 10.1016/j.jep.2013.08.054.", "ArticleIdList": ["10.1016/j.jep.2013.08.054", "24095700"]}, {"Citation": "Jia Y, Wang H, Song Y, Liu K, Dou F, Lu C, Ge J, Chi N, Ding Y, Hai W, Wen A. Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of Brazilin in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;931:61\u201367. doi: 10.1016/j.jchromb.2013.05.017.", "ArticleIdList": ["10.1016/j.jchromb.2013.05.017", "23777611"]}, {"Citation": "Li M, Dong X, Liu Y, Sun Y. Brazilin inhibits prostatic acidic phosphatase fibrillogenesis and decreases its cytotoxicity. Chem Asian J. 2017;12:1062\u20131068. doi: 10.1002/asia.201700058.", "ArticleIdList": ["10.1002/asia.201700058", "28303660"]}, {"Citation": "Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update. Food Chem Toxicol. 2015;83:111\u2013124. doi: 10.1016/j.fct.2015.05.022.", "ArticleIdList": ["10.1016/j.fct.2015.05.022", "26066364"]}, {"Citation": "He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015;20:9183\u20139213. doi: 10.3390/molecules20059183.", "ArticleIdList": ["10.3390/molecules20059183", "PMC6272784", "26007179"]}, {"Citation": "Lin C-F, Yu K-H, Jheng C-P, Chung R, Lee C-I. Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress. Pathogens. 2013;2:506\u2013519. doi: 10.3390/pathogens2030506.", "ArticleIdList": ["10.3390/pathogens2030506", "PMC4235698", "25437204"]}, {"Citation": "Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK. Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice. PLoS One. 2015;10:e0128510. doi: 10.1371/journal.pone.0128510.", "ArticleIdList": ["10.1371/journal.pone.0128510", "PMC4452784", "26035833"]}, {"Citation": "Yanagisawa D, Shirai N, Amatsubo T, Taguchi H, Hirao K, Urushitani M, Morikawa S, Inubushi T, Kato M, Kato F, Morino K, Kimura H, Nakano I, Yoshida C, Okada T, Sano M, Wada Y, Wada K, Yamamoto A, Tooyama I. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer\u2019s disease. Biomaterials. 2010;31:4179\u20134185. doi: 10.1016/j.biomaterials.2010.01.142.", "ArticleIdList": ["10.1016/j.biomaterials.2010.01.142", "20181392"]}, {"Citation": "Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280:5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Rao PPN, Mohamed T, Teckwani K, Tin G. Curcumin binding to beta amyloid: a computational study. Chem Biol Drug Des. 2015;86:813\u2013820. doi: 10.1111/cbdd.12552.", "ArticleIdList": ["10.1111/cbdd.12552", "25776887"]}, {"Citation": "Baum L, Lam CWK, Cheung SK-K, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HFK, Goggins WB, Zee BCY, Cheng KF, Fong CYS, Wong A, Mok H, Chow MSS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CYL, Chan M-H, Szeto S, Chan IHS, Mok V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28:110\u2013113. doi: 10.1097/jcp.0b013e318160862c.", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol. 2008;115:479\u2013489. doi: 10.1007/s00401-007-0332-4.", "ArticleIdList": ["10.1007/s00401-007-0332-4", "18189141"]}, {"Citation": "Siddique YH, Naz F, Jyoti S. Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic Drosophila model of Parkinson\u2019s disease. Biomed Res Int. 2014;2014:606928.", "ArticleIdList": ["PMC4016861", "24860828"]}, {"Citation": "Daval M, Bedrood S, Gurlo T, Huang C-J, Costes S, Butler PC, Langen R. The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid. 2010;17:118\u2013128. doi: 10.3109/13506129.2010.530008.", "ArticleIdList": ["10.3109/13506129.2010.530008", "PMC4394664", "21067307"]}, {"Citation": "Sparks S, Liu G, Robbins KJ, Lazo ND. Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling \u03b1-helix. Biochem Biophys Res Commun. 2012;422:551\u2013555. doi: 10.1016/j.bbrc.2012.05.013.", "ArticleIdList": ["10.1016/j.bbrc.2012.05.013", "22579683"]}, {"Citation": "Caughey B, Raymond LD, Raymond GJ, Maxson L, Silveira J, Baron GS. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol. 2003;77:5499\u20135502. doi: 10.1128/JVI.77.9.5499-5502.2003.", "ArticleIdList": ["10.1128/JVI.77.9.5499-5502.2003", "PMC153975", "12692251"]}, {"Citation": "Hafner-Bratkovic I, Gaspersic J, Smid LM, Bresjanac M, Jerala R. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein: a new mechanism for the inhibition of PrP(Sc) accumulation. J Neurochem. 2008;104:1553\u20131564. doi: 10.1111/j.1471-4159.2007.05105.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.05105.x", "17996023"]}, {"Citation": "Saelices L, Johnson LM, Liang WY, Sawaya MR, Cascio D, Ruchala P, Whitelegge J, Jiang L, Riek R, Eisenberg DS. Uncovering the mechanism of aggregation of human transthyretin. J Biol Chem. 2015;290:28932\u201328943. doi: 10.1074/jbc.M115.659912.", "ArticleIdList": ["10.1074/jbc.M115.659912", "PMC4661406", "26459562"]}, {"Citation": "Ferreira N, Santos SAO, Domingues MRM, Saraiva MJ, Almeida MR. Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition. Biochim Biophys Acta Mol Basis Dis. 2013;1832:39\u201345. doi: 10.1016/j.bbadis.2012.10.007.", "ArticleIdList": ["10.1016/j.bbadis.2012.10.007", "23069388"]}, {"Citation": "Ahsan N, Mishra S, Jain MK, Surolia A, Gupta S. Curcumin pyrazole and its derivative (N-(3-nitrophenylpyrazole) curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of wild type and mutant \u03b1-synuclein. Sci Rep. 2015;5:9862. doi: 10.1038/srep09862.", "ArticleIdList": ["10.1038/srep09862", "PMC4435243", "25985292"]}, {"Citation": "Del Rio D, Stewart AJ, Mullen W, Burns J, Lean MEJ, Brighenti F, Crozier A. HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. J Agric Food Chem. 2004;52:2807\u20132815. doi: 10.1021/jf0354848.", "ArticleIdList": ["10.1021/jf0354848", "15137818"]}, {"Citation": "Liu Y, Pukala TL, Musgrave IF, Williams DM, Dehle FC, Carver JA. Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation. Bioorg Med Chem Lett. 2013;23:6336\u20136340. doi: 10.1016/j.bmcl.2013.09.071.", "ArticleIdList": ["10.1016/j.bmcl.2013.09.071", "24157371"]}, {"Citation": "Liu Y, Carver JA, Calabrese AN, Pukala TL. Gallic acid interacts with \u03b1-synuclein to prevent the structural collapse necessary for its aggregation. Biochim Biophys Acta. 2014;1844:1481\u20131485. doi: 10.1016/j.bbapap.2014.04.013.", "ArticleIdList": ["10.1016/j.bbapap.2014.04.013", "24769497"]}, {"Citation": "Jayamani J, Shanmugam G. Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Eur J Med Chem. 2014;85:352\u2013358. doi: 10.1016/j.ejmech.2014.07.111.", "ArticleIdList": ["10.1016/j.ejmech.2014.07.111", "25105923"]}, {"Citation": "Fujiwara H, Tabuchi M, Yamaguchi T, Iwasaki K, Furukawa K, Sekiguchi K, Ikarashi Y, Kudo Y, Higuchi M, Saido TC, Maeda S, Takashima A, Hara M, Yaegashi N, Kase Y, Arai H. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-d-glucopyranose have potent anti-aggregation effects on Alzheimer\u2019s amyloid beta proteins in vitro and in vivo. J Neurochem. 2009;109:1648\u20131657. doi: 10.1111/j.1471-4159.2009.06069.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06069.x", "19457098"]}, {"Citation": "Bruno E, Pereira C, Roman KP, Takiguchi M, Kao P-Y, Nogaj LA, Moffet DA. IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-\u03b2-d-glucose. Amyloid. 2013;20:34\u201338. doi: 10.3109/13506129.2012.762761.", "ArticleIdList": ["10.3109/13506129.2012.762761", "PMC3957415", "23339420"]}, {"Citation": "Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorgan Med Chem. 2012;20:6669\u20136679. doi: 10.1016/j.bmc.2012.09.040.", "ArticleIdList": ["10.1016/j.bmc.2012.09.040", "23062825"]}, {"Citation": "Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993\u2013999. doi: 10.1016/0006-291X(90)91544-3.", "ArticleIdList": ["10.1016/0006-291X(90)91544-3", "2244923"]}, {"Citation": "Kim T, Hinton DJ, Choi D. Protein kinase C-regulated A\u03b2 production and clearance. Int J Alzheimers Dis. 2011;2011:857368.", "ArticleIdList": ["PMC3026967", "21274428"]}, {"Citation": "Ma W, Zheng WH, Belanger S, Kar S, Quirion R. Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C. Eur J Neurosci. 2001;13:1125\u20131135. doi: 10.1046/j.1460-9568.2001.01475.x.", "ArticleIdList": ["10.1046/j.1460-9568.2001.01475.x", "11285010"]}, {"Citation": "Ba F, Pang PKT, Benishin CG. The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J Neurosci Methods. 2003;123:11\u201322. doi: 10.1016/S0165-0270(02)00324-2.", "ArticleIdList": ["10.1016/S0165-0270(02)00324-2", "12581845"]}, {"Citation": "Pitt J, Roth W, Lacor P, Smith AB, Blankenship M, Velasco P, De Felice F, Breslin P, Klein WL. Alzheimer\u2019s-associated A\u03b2 oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol. 2009;240:189\u2013197. doi: 10.1016/j.taap.2009.07.018.", "ArticleIdList": ["10.1016/j.taap.2009.07.018", "PMC2808212", "19631677"]}, {"Citation": "Li W, Sperry JB, Crowe A, Trojanowski JQ, Smith AB, Lee VMY. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J Neurochem. 2009;110:1339\u20131351. doi: 10.1111/j.1471-4159.2009.06224.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06224.x", "PMC2758489", "19549281"]}, {"Citation": "Qosa H, Batarseh YS, Mohyeldin MM, El Sayed KA, Keller JN, Kaddoumi A. Oleocanthal enhances amyloid-\u03b2 clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci. 2015;6:1849\u20131859. doi: 10.1021/acschemneuro.5b00190.", "ArticleIdList": ["10.1021/acschemneuro.5b00190", "PMC4653763", "26348065"]}, {"Citation": "Galanakis PA, Bazoti FN, Bergquist J, Markides K, Spyroulias GA, Tsarbopoulos A. Study of the interaction between the amyloid beta peptide (1\u201340) and antioxidant compounds by nuclear magnetic resonance spectroscopy. Biopolymers. 2011;96:316\u2013327. doi: 10.1002/bip.21558.", "ArticleIdList": ["10.1002/bip.21558", "21053258"]}, {"Citation": "Kostomoiri M, Fragkouli A, Sagnou M, Skaltsounis LA, Pelecanou M, Tsilibary EC, Tzinia AK. Oleuropein, an anti-oxidant polyphenol constituent of olive promotes \u03b1-secretase cleavage of the amyloid precursor protein (A\u03b2PP) Cell Mol Neurobiol. 2013;33:147\u2013154. doi: 10.1007/s10571-012-9880-9.", "ArticleIdList": ["10.1007/s10571-012-9880-9", "23053546"]}, {"Citation": "Daccache A, Lion C, Sibille N, Gerard M, Slomianny C, Lippens G, Cotelle P. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int. 2011;58:700\u2013707. doi: 10.1016/j.neuint.2011.02.010.", "ArticleIdList": ["10.1016/j.neuint.2011.02.010", "21333710"]}, {"Citation": "Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, Berti A, Stefani M. A\u03b2(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res. 2011;8:841\u2013852. doi: 10.2174/156720511798192682.", "ArticleIdList": ["10.2174/156720511798192682", "21592051"]}, {"Citation": "Luccarini I, Grossi C, Rigacci S, Coppi E, Pugliese AM, Pantano D, la Marca G, Ed Dami T, Berti A, Stefani M, Casamenti F. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-\u0394 toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging. 2015;36:648\u2013663. doi: 10.1016/j.neurobiolaging.2014.08.029.", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.08.029", "25293421"]}, {"Citation": "Diomede L, Rigacci S, Romeo M, Stefani M, Salmona M. Oleuropein aglycone protects transgenic C. elegans strains expressing A\u03b242 by reducing plaque load and motor deficit. PLoS One. 2013 doi: 10.1371/journal.pone.0058893.", "ArticleIdList": ["10.1371/journal.pone.0058893", "PMC3592812", "23520540"]}, {"Citation": "Grossi C, Rigacci S, Ambrosini S, Ed Dami T, Luccarini I, Traini C, Failli P, Berti A, Casamenti F, Stefani M. The polyphenol oleuropein aglycone protects TgCRND8 mice against A\u00df plaque pathology. PLoS One. 2013;8:e71702. doi: 10.1371/journal.pone.0071702.", "ArticleIdList": ["10.1371/journal.pone.0071702", "PMC3738517", "23951225"]}, {"Citation": "Grossi C, EdDami T, Rigacci S, Stefani M, Luccarini I, Casamenti F. Employing Alzheimer disease animal models for translational research: focus on dietary components. Neurodegener Dis. 2014;13:131\u2013134. doi: 10.1159/000355461.", "ArticleIdList": ["10.1159/000355461", "24192327"]}, {"Citation": "Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, Cerbai E, Stefani M, Berti A. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem. 2010;21:726\u2013735. doi: 10.1016/j.jnutbio.2009.04.010.", "ArticleIdList": ["10.1016/j.jnutbio.2009.04.010", "19616928"]}, {"Citation": "Palazzi L, Bruzzone E, Bisello G, Leri M, Stefani M, Bucciantini M, Polverino de Laureto P. Oleuropein aglycone stabilizes the monomeric \u03b1-synuclein and favours the growth of non-toxic aggregates. Sci Rep. 2018;8:8337. doi: 10.1038/s41598-018-26645-5.", "ArticleIdList": ["10.1038/s41598-018-26645-5", "PMC5974307", "29844450"]}, {"Citation": "Leri M, Nosi D, Natalello A, Porcari R, Ramazzotti M, Chiti F, Bellotti V, Doglia SM, Stefani M, Bucciantini M. The polyphenol oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. J Nutr Biochem. 2016;30:153\u2013166. doi: 10.1016/j.jnutbio.2015.12.009.", "ArticleIdList": ["10.1016/j.jnutbio.2015.12.009", "27012632"]}, {"Citation": "Bieschke J, Herbst M, Wiglenda T, Friedrich RP, Boeddrich A, Schiele F, Kleckers D, Lopez Del Amo JM, Gr\u00fcning BA, Wang Q, Schmidt MR, Lurz R, Anwyl R, Schnoegl S, F\u00e4ndrich M, Frank RF, Reif B, G\u00fcnther S, Walsh DM, Wanker EE. Small-molecule conversion of toxic oligomers to nontoxic \u03b2-sheet-rich amyloid fibrils. Nat Chem Biol. 2011;8:93\u2013101. doi: 10.1038/nchembio.719.", "ArticleIdList": ["10.1038/nchembio.719", "22101602"]}, {"Citation": "Lam HT, Graber MC, Gentry KA, Bieschke J. Stabilization of \u03b1-synuclein fibril clusters prevents fragmentation and reduces seeding activity and toxicity. Biochemistry. 2016;55:675\u2013685. doi: 10.1021/acs.biochem.5b01168.", "ArticleIdList": ["10.1021/acs.biochem.5b01168", "PMC5706464", "26799377"]}, {"Citation": "Gao M, Estel K, Seeliger J, Friedrich RP, Dogan S, Wanker EE, Winter R, Ebbinghaus S. Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones. Phys Chem Chem Phys. 2015;17:8338\u20138348. doi: 10.1039/C4CP04682J.", "ArticleIdList": ["10.1039/C4CP04682J", "25406896"]}, {"Citation": "Ladiwala ARA, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, Tessier PM. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem. 2010;285:24228\u201324237. doi: 10.1074/jbc.M110.133108.", "ArticleIdList": ["10.1074/jbc.M110.133108", "PMC2911349", "20511235"]}, {"Citation": "Ge JF, Qiao JP, Qi CC, Wang CW, Zhou JN. The binding of resveratrol to monomer and fibril amyloid beta. Neurochem Int. 2012;61:1192\u20131201. doi: 10.1016/j.neuint.2012.08.012.", "ArticleIdList": ["10.1016/j.neuint.2012.08.012", "22981725"]}, {"Citation": "Feng Y, Wang XP, Yang SG, Wang YJ, Zhang X, Du XT, Sun XX, Zhao M, Huang L, Liu RT. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology. 2009;30:986\u2013995. doi: 10.1016/j.neuro.2009.08.013.", "ArticleIdList": ["10.1016/j.neuro.2009.08.013", "19744518"]}, {"Citation": "He X, Li Z, Rizak JD, Wu S, Wang Z, He R, Su M, Qin D, Wang J, Hu X. Resveratrol attenuates formaldehyde induced hyperphosphorylation of tau protein and cytotoxicity in N2a cells. Front: Neuroscience; 2017.", "ArticleIdList": ["PMC5281604", "28197064"]}, {"Citation": "Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. Neurochem Int. 2009;54:111\u2013118. doi: 10.1016/j.neuint.2008.10.008.", "ArticleIdList": ["10.1016/j.neuint.2008.10.008", "PMC2892907", "19041676"]}, {"Citation": "Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides. J Biol Chem. 2005;280:37377\u201337382. doi: 10.1074/jbc.M508246200.", "ArticleIdList": ["10.1074/jbc.M508246200", "16162502"]}, {"Citation": "Wang R, Zhang Y, Li J, Zhang C. Resveratrol ameliorates spatial learning memory impairment induced by A\u03b21-42 in rats. Neuroscience. 2017;344:39\u201347. doi: 10.1016/j.neuroscience.2016.08.051.", "ArticleIdList": ["10.1016/j.neuroscience.2016.08.051", "27600946"]}, {"Citation": "Porquet D, Gri\u00f1\u00e1n-Ferr\u00e9 C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pall\u00e0s M. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:1209\u20131220. doi: 10.3233/JAD-140444.", "ArticleIdList": ["10.3233/JAD-140444", "25024312"]}, {"Citation": "Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT. Resveratrol decreases the insoluble A\u03b21-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience. 2015;310:641\u2013649. doi: 10.1016/j.neuroscience.2015.10.006.", "ArticleIdList": ["10.1016/j.neuroscience.2015.10.006", "26454022"]}, {"Citation": "Yao Y, Li J, Niu Y, Yu J, Yan L, Miao Z, Zhao X, Li Y, Yao W, Zheng P, Li W. Resveratrol inhibits oligomeric Abeta-induced microglial activation via NADPH oxidase. Mol: Med Rep; 2015.", "ArticleIdList": ["26252250"]}, {"Citation": "Huang TC, Lu KT, Wo YYP, Wu YJ, Yang YL. Resveratrol protects rats from A\u03b2-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One. 2011;6:e29102. doi: 10.1371/journal.pone.0029102.", "ArticleIdList": ["10.1371/journal.pone.0029102", "PMC3248406", "22220203"]}, {"Citation": "Loureiro JA, Andrade S, Duarte A, Neves AR, Queiroz JF, Nunes C, Sevin E, Fenart L, Gosselet F, Coelho MAN, Pereira MC, Latruffe N. Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease. Molecules. 2017;22:E277. doi: 10.3390/molecules22020277.", "ArticleIdList": ["10.3390/molecules22020277", "PMC6155722", "28208831"]}, {"Citation": "K\u00f6be T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J, Grittner U, Fl\u00f6el A. Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment. Front Neurosci. 2017 doi: 10.3389/fnins.2017.00105.", "ArticleIdList": ["10.3389/fnins.2017.00105", "PMC5339301", "28326010"]}, {"Citation": "Turner RS, Thomas RG, Craft S, Van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85:1383\u20131391. doi: 10.1212/WNL.0000000000002035.", "ArticleIdList": ["10.1212/WNL.0000000000002035", "PMC4626244", "26362286"]}, {"Citation": "Pithadia A, Brender JR, Fierke CA, Ramamoorthy A. Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J Diabetes Res. 2016;2016:2046327. doi: 10.1155/2016/2046327.", "ArticleIdList": ["10.1155/2016/2046327", "PMC4662995", "26649317"]}, {"Citation": "Wang Q, Ning L, Niu Y, Liu H, Yao X. Molecular mechanism of the inhibition and remodeling of human islet amyloid polypeptide (hIAPP(1\u201337)) oligomer by resveratrol from molecular dynamics simulation. J Phys Chem B. 2015;119:15\u201324. doi: 10.1021/jp507529f.", "ArticleIdList": ["10.1021/jp507529f", "25494644"]}, {"Citation": "Lolicato F, Raudino A, Milardi D, La Rosa C. Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. Eur J Med Chem. 2015;92:876\u2013881. doi: 10.1016/j.ejmech.2015.01.047.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.047", "25638571"]}, {"Citation": "Tu LH, Young LM, Wong AG, Ashcroft AE, Radford SE, Raleigh DP. Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions. Biochemistry. 2015;54:666\u2013676. doi: 10.1021/bi501016r.", "ArticleIdList": ["10.1021/bi501016r", "PMC4310630", "25531836"]}, {"Citation": "Nedumpully-Govindan P, Kakinen A, Pilkington EH, Davis TP, Ke PC, Ding F. Stabilizing off-pathway oligomers by polyphenol nanoassemblies for IAPP aggregation inhibition. Sci Rep. 2016;6:19463. doi: 10.1038/srep19463.", "ArticleIdList": ["10.1038/srep19463", "PMC4725907", "26763863"]}, {"Citation": "Wei L, Jiang P, Xu W, Li H, Zhang H, Yan L, Chan-Park MB, Liu XW, Tang K, Mu Y, Pervushin K. The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. J Biol Chem. 2011;286:6291\u20136300. doi: 10.1074/jbc.M110.166678.", "ArticleIdList": ["10.1074/jbc.M110.166678", "PMC3057848", "21148563"]}, {"Citation": "Jiang P, Li W, Shea JE, Mu Y. Resveratrol inhibits the formation of multiple-layered \u03b2-Sheet oligomers of the human islet amyloid polypeptide segment 22\u201327. Biophys J. 2011;100:1550\u20131558. doi: 10.1016/j.bpj.2011.02.010.", "ArticleIdList": ["10.1016/j.bpj.2011.02.010", "PMC3059578", "21402038"]}, {"Citation": "Mishra R, Sellin D, Radovan D, Gohlke A, Winter R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem. 2009;10:445\u2013449. doi: 10.1002/cbic.200800762.", "ArticleIdList": ["10.1002/cbic.200800762", "19165839"]}, {"Citation": "Sciacca MFM, Chillemi R, Sciuto S, Greco V, Messineo C, Kotler SA, Lee DK, Brender JR, Ramamoorthy A, La Rosa C, Milardi D. A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim Biophys Acta Biomembr. 2018 doi: 10.1016/j.bbamem.2018.03.012.", "ArticleIdList": ["10.1016/j.bbamem.2018.03.012", "29555190"]}, {"Citation": "Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, N\u00e9ri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet. 2005;37:349\u2013350. doi: 10.1038/ng1534.", "ArticleIdList": ["10.1038/ng1534", "15793589"]}, {"Citation": "Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC. Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol. 2000;7:312\u2013321. doi: 10.1038/74082.", "ArticleIdList": ["10.1038/74082", "10742177"]}, {"Citation": "Akasaki Y, Reixach N, Matsuzaki T, Alvarez-Garcia O, Olmer M, Iwamoto Y, Buxbaum JN, Lotz MK. Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis. Arthritis Rheumatol. 2015;67:2097\u20132107. doi: 10.1002/art.39178.", "ArticleIdList": ["10.1002/art.39178", "PMC4519374", "25940564"]}, {"Citation": "Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro. J Neurosci Res. 2004;75:742\u2013750. doi: 10.1002/jnr.20025.", "ArticleIdList": ["10.1002/jnr.20025", "14994335"]}, {"Citation": "Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M. Natural phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis. Adv Exp Med Biol. 2015;863:79\u201395. doi: 10.1007/978-3-319-18365-7_4.", "ArticleIdList": ["10.1007/978-3-319-18365-7_4", "26092627"]}, {"Citation": "Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki JI, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M. Phenolic compounds prevent amyloid \u03b2-protein oligomerization and synaptic dysfunction by site specific binding. J Biol Chem. 2012;287:14631\u201314643. doi: 10.1074/jbc.M111.325456.", "ArticleIdList": ["10.1074/jbc.M111.325456", "PMC3340280", "22393064"]}, {"Citation": "Iuvone T, De Filippis D, Esposito G, Amico AD, Izzo AA, D\u2019Amico A. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther. 2006;317:1143\u20131149. doi: 10.1124/jpet.105.099317.", "ArticleIdList": ["10.1124/jpet.105.099317", "16495207"]}, {"Citation": "Lee AY, Hwang BR, Lee MH, Lee S, Cho EJ. Perilla frutescens var. japonica and rosmarinic acid improve amyloid-\u03b225\u201335 induced impairment of cognition and memory function. Nutr Res Pract. 2016;10:274\u2013281. doi: 10.4162/nrp.2016.10.3.274.", "ArticleIdList": ["10.4162/nrp.2016.10.3.274", "PMC4880726", "27247723"]}, {"Citation": "Hamaguchi T, Ono K, Murase A, Yamada M. Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol. 2009;175:2557\u20132565. doi: 10.2353/ajpath.2009.090417.", "ArticleIdList": ["10.2353/ajpath.2009.090417", "PMC2789642", "19893028"]}, {"Citation": "Ramazzotti M, Melani F, Marchi L, Mulinacci N, Gestri S, Tiribilli B, Degl\u2019Innocenti D. Mechanisms for the inhibition of amyloid aggregation by small ligands. Biosci Rep. 2016;36:e00385. doi: 10.1042/BSR20160101.", "ArticleIdList": ["10.1042/BSR20160101", "PMC5041158", "27512096"]}, {"Citation": "Shariatizi S, Meratan AA, Ghasemi A, Nemat-Gorgani M. Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols. Int J Biol Macromol. 2015;80:95\u2013106. doi: 10.1016/j.ijbiomac.2015.06.030.", "ArticleIdList": ["10.1016/j.ijbiomac.2015.06.030", "26102331"]}, {"Citation": "Rashidi AA, Mirhashemi SM, Taghizadeh M, Sarkhail P. Iranian medicinal plants for diabetes mellitus: a systematic review. Pakistan J Biol Sci PJBS. 2013;16:401\u2013411. doi: 10.3923/pjbs.2013.401.411.", "ArticleIdList": ["10.3923/pjbs.2013.401.411", "24498803"]}, {"Citation": "Zheng Q, Lazo LD. Mechanistic studies of the inhibition of insulin fibril formation by rosmarinic acid. J Phys Chem B. 2018;122:2323\u20132331. doi: 10.1021/acs.jpcb.8b00689.", "ArticleIdList": ["10.1021/acs.jpcb.8b00689", "29401384"]}, {"Citation": "Ono K, Hasegawa K, Naiki H, Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer\u2019s beta-amyloid fibrils in vitro. Biochim Biophys Acta. 2004;1690:193\u2013202. doi: 10.1016/j.bbadis.2004.06.008.", "ArticleIdList": ["10.1016/j.bbadis.2004.06.008", "15511626"]}, {"Citation": "Kocisko DA, Engel AL, Harbuck K, Arnold KM, Olsen EA, Raymond LD, Vilette D, Caughey B. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie. Neurosci Lett. 2005;388:106\u2013111. doi: 10.1016/j.neulet.2005.06.053.", "ArticleIdList": ["10.1016/j.neulet.2005.06.053", "16039063"]}, {"Citation": "Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B. New inhibitors of scrapie-associated prion protein formation in a Library of 2,000 drugs and natural products. J Virol. 2003;77:10288\u201310294. doi: 10.1128/JVI.77.19.10288-10294.2003.", "ArticleIdList": ["10.1128/JVI.77.19.10288-10294.2003", "PMC228499", "12970413"]}, {"Citation": "Wolfe LL, Kocisko DA, Caughey B, Miller MW. Assessment of prospective preventive therapies for chronic wasting disease in Mule Deer. J Wildl Dis. 2012;48:530\u2013533. doi: 10.7589/0090-3558-48.2.530.", "ArticleIdList": ["10.7589/0090-3558-48.2.530", "PMC4780682", "22493139"]}, {"Citation": "Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, L\u00fc J. Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci. 2012;13:13621\u201313666. doi: 10.3390/ijms131013621.", "ArticleIdList": ["10.3390/ijms131013621", "PMC3497345", "23202971"]}, {"Citation": "Wang Q, Yu X, Patal K, Hu R, Chuang S, Zhang G, Zheng J. Tanshinones inhibit amyloid aggregation by amyloid-\u03b2 peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci. 2013;4:1004\u20131015. doi: 10.1021/cn400051e.", "ArticleIdList": ["10.1021/cn400051e", "PMC3756451", "23506133"]}, {"Citation": "Mei Z, Yan P, Situ B, Mou Y, Liu P. Cryptotanshinione inhibits \u03b2-amyloid aggregation and protects damage from \u03b2-amyloid in SH-SY5Y cells. Neurochem Res. 2012;37:622\u2013628. doi: 10.1007/s11064-011-0652-6.", "ArticleIdList": ["10.1007/s11064-011-0652-6", "22102154"]}, {"Citation": "Ji K, Zhao Y, Yu T, Wang Z, Gong H, Yang X, Liu Y, Huang K. Inhibition effects of tanshinone on the aggregation of \u03b1-synuclein. Food Funct. 2016;7:409\u2013416. doi: 10.1039/C5FO00664C.", "ArticleIdList": ["10.1039/C5FO00664C", "26456030"]}, {"Citation": "Maione F, Piccolo M, De Vita S, Chini MG, Cristiano C, De Caro C, Lippiello P, Miniaci MC, Santamaria R, Irace C, De Feo V, Calignano A, Mascolo N, Bifulco G. Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease. Pharmacol Res. 2018;129:482\u2013490. doi: 10.1016/j.phrs.2017.11.018.", "ArticleIdList": ["10.1016/j.phrs.2017.11.018", "29158049"]}]}], "History": [{"Year": "2018", "Month": "1", "Day": "29"}, {"Year": "2018", "Month": "7", "Day": "9"}, {"Year": "2018", "Month": "6", "Day": "12"}, {"Year": "2018", "Month": "7", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30030591", "PMC11105286", "10.1007/s00018-018-2872-2", "10.1007/s00018-018-2872-2"]}}]}